BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15853229)

  • 1. [Thyroid carcinoma].
    Tamaki H
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):561-5. PubMed ID: 15853229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
    Carmignani F; Piscopello L; Sammartini C
    Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers for endocrine neoplasms].
    Okamoto T
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
    Quayle FJ; Moley JF
    J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
    Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report.
    Unruh A; Fitze G; Jänig U; Bielack S; Lochbühler H; Coerdt W
    J Pediatr Surg; 2007 Sep; 42(9):1623-6. PubMed ID: 17848262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medullary carcinoma of the thyroid: diagnosis and therapy].
    Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
    Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medullary thyroid carcinoma and other rare types of thyroid carcinoma].
    Obara T
    Nihon Rinsho; 2007 Nov; 65(11):2087-91. PubMed ID: 18018575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological investigation of thyroid cancer].
    Douik H; Ghanem A; Jmal A; Harzallah L; Gara S; Abdennebi M; Boussen H; Guemira F
    Tunis Med; 2006 Mar; 84(3):135-41. PubMed ID: 16755952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of multiple endocrine neoplasia type 2B undiagnosed for many years despite its typical phenotype.
    Ohyama T; Sato M; Murao K; Kittaka K; Namihira H; Matsubara S; Imachi H; Yamauchi K; Takahara J
    Endocrine; 2001 Jul; 15(2):143-6. PubMed ID: 11720239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated and medullary thyroid cancer in childhood and adolescence.
    La Quaglia MP; Telander RL
    Semin Pediatr Surg; 1997 Feb; 6(1):42-9. PubMed ID: 9117274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
    Heshmati HM; Hofbauer LC
    Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular manifestations in multiple endocrine neoplasia type 2b.
    Fink A; Lapidot M; Spierer A
    Am J Ophthalmol; 1998 Aug; 126(2):305-7. PubMed ID: 9727527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
    Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
    Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral markers for thyroid carcinoma.
    Pacini F; Martino E; Bambini G; Aghini-Lombardi F; Taddei D; Lari R; Pinchera A; Baschieri L
    Cancer Detect Prev; 1985; 8(1-2):17-22. PubMed ID: 4064037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medullary thyroid carcinoma--familial or sporadic disease?].
    Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
    Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.